Delivery systems and adjuvants for vaccination against HIV

Pathobiology

Volumn 66, Issue 3-4, 1998, Pages 170-175

  Velin, Dominique ^a,c   Hopkins, Sally ^a,b   Kraehenbuhl, Jean Pierre ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Adenovirus; Adjuvant; DNA; HIV; Mucosa; Vaccine

Indexed keywords

CHOLERA TOXIN; DNA; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; RECOMBINANT VACCINE; VIRUS ANTIGEN;

ADENOVIRUS; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MUCOSA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA; UTERINE CERVIX MUCOSA; VACCINATION; VAGINA MUCOSA; VIRUS IMMUNITY; VIRUS RECOMBINANT;

ADMINISTRATION, ORAL; AIDS VACCINES; CHOLERA TOXIN; DRUG DELIVERY SYSTEMS; HIV INFECTIONS; HUMANS; INTESTINAL MUCOSA; SALMONELLA TYPHIMURIUM; VACCINATION; VACCINES, SYNTHETIC;

ADENOVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SALMONELLA;

EID: 0031868418     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028017     Document Type: Conference Paper

References (31)

1. Chin, J: Global estimates of AIDS and HIV infections. AIDS (Lond) 1990;4:S277-S283.
2. Milman, G, Sharma O: Mechanisms of HIV/SIV mucosal transmission. AIDS Res Hum Retroviruses 1994;10:1305-1309.
3. Spira, AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, Ho DD: Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-225.
4. Bomsel M: Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 1997;3:42-47.
5. Amerongen HM, Weltzin RA, Farnet CM, Michetti P, Haseltine WA, Neutra MR: Transepithelial transport of HIV-1 by intestinal M-cells: A mechanism for transmission of AIDS. J Acquir Immune Defic Syndr 1991;4:760-765.
6. Haynes BF, Pantaleo G, Fauci AA: Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996;271: 324-328.
7. Parren PW, Burton DJ, Sattenau QJ: HIV-1 antibody - Debris or virion? Nat Med 1997;3: 366.
8. Karpas A, Ash S, Bainbridge D: Imponance of anti-HIV-1 antibodies. Nat Med 1997;3:590-591.
9. Kraehenbuhl JP, Neutra MR: Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev 1992;72:853-879.
10. Munoz JL, McCarthy CA, Clark ME, Hall CB: Respiratory syncytial virus infection in C57BL/6 mice: Clearance of virus from the lungs with virus-specific cytotoxic T cells. J Virol 1991;65:4494-4497.
11. Mazanec MB, Coudret CL, Fletcher DR: Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 1995;69:1339-1343.
12. Burns JW, Siadat-Pajouh M, Krishnaney AA, Breenberg HB: Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996;272: 104-107.
13. Pappo J, Owen RL: Absence of secretory component expression by epithelial cells overlying rabbit gut-associated lymphoid tissue. Gastroenterology 1988;95:1173-1177.
14. Allan CH, Trier JS: Structure and permeability differ in subepithelial villus and Peyer's patch follicle capillaries. Gastroenterology 1991;100: 1172-1179.
15. Held W, Waanders G, Shakhov AN, Scarpellino L, Acha-Orbea H, MacDonald HR: Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 1993;74:529-540.
16. Karapetian O, Shakhov AN, Kraeaenbuhl JP, Acha-Orbea H: Retroviral infection of neonatal Fever's patch lymphocytes: The mouse mammary tumor virus model. J Exp Med 1994;180: 1511-1516.
17. Acha-Orbea H, Scarpellino L, Shakhov AN, Held W, MacDonald HR: Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein. J Exp Med 1992;176:1769-1772.
18. Hopkins S, Kraehenbuhl JP, Schödel F, Potts A, Peterson D, De Grandi P, Nardelli-Haefliger D: A recombinant S. typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 1995;63: 3279-3286.
19. Aggarwal AS, Jaffe R, Hone D, Gross M, Sadoff J: Oral Salmonella: Malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J Exp Med 1990;172:1083-1090.
20. Elson CO, Dertzbaugh MT: Mucosal adjuvants; in Ogra PL, Lamm ME, McGhee JR, Mestecky J, Strober W, Bienenstock J (eds): Handbook of Mucosal Immunology. San Diego, Academic Press, 1994, p 391.
21. Bowen JC, Nair SK, Reddy R, Rouse BT: Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens. Immunology 1994;81:338-342.
22. Van Heyningen S: Cholera toxin: Interaction of subumts with ganglioside αGM1. Science 1974;183:656-657.
23. Gill DM, King CA: The mechanism of the action of cholera toxin in pigeon erythrocyte lysates. J Biol Chem 1975;250:6424-6432.
24. Field M, Rao MC, Chang EB: Intestinal electrolyte transport and diarrheal disease. N Engl J Med 1989;321:800-806.
25. Yamamoto S, Kiyono H, Yamamoto M, Imaoka K, Yamamoto M, Fujihashi K, Van Ginkel FW, Noda M, Takeda Y, McGhee JR: A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci USA 1997;94:5267-5272.
26. Gallichan WS, Rosenthal K: Specific secretory immune responses in the female genital tract following intranasal immunization with recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 1995;13: 1589-1595.
27. Gallichan WS, Rosenthal K: Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J Exp Med 1996;184:1879-1890.
28. Lubeck MD, Natuk R, Myagkikh M, Kalyan N, Aldrich K, Sinangil F, Alipanah S, Murthy SCS, Chanda PK, Nigida SM, Markhan PD, Zolla-Pazner S, Steimer K, Wade M, Reitz MS, Arthur L, Mizutani S, Davis A, Hung PP, Gallo RC, Eichberg J, Robert-Guroff M: Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Nat Med 1997;3:651-658.
29. Boyer JDO, Ugen KE, Wang B, Agadjanyan M, Gilbert L, Bagarazzi ML, Chattergoon M, Frost P, Javadian A, Williams WV, Rafaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997;3:526-532.
30. Fynan EF, Webster RG, Fuller DH, Haynes JR. Santoro JC, Robison HL: DNA vaccines: Protective immunization by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993;90:11478-11482.
31. Kraehenbuhl JP, Wain-Hobson S: Breaching barriers. Nat Med 1996;2:1080-1082.